Back

BEHAVE-HTN: subanalysis of a randomized trial evaluating timing adherence with a multifaceted mHealth intervention and financial incentives

29 August 2026 (09:15 - 10:00)
Organised by: Logo
Congress Presentation Part of: Artificial intelligence and digital tools in cardiovascular care m-Health & Mobile Apps ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Annina Vischer

University Hospital Basel, Basel (Switzerland)

5 More presentations in this session

Presentation thumbnail
“Smart-Film” device to improve medication adherence to apixaban in patients with atrial fibrillation: a randomized controlled trial
Doctor H. Sim (Singapore, SG)
Abstract
Presentation thumbnail
Baseline clinical phenotypes of patients initiating a digital health application (DiGA) for hypertension: real-world evidence from a German cohort
Professor F. Limbourg (Hannover, DE)
Abstract
Presentation thumbnail
Mobile app implementation in chronic ambulatory heart failure patients for improving outcomes in low-middle income countries
Doctor V. Gomez Lopez (Mexico City, MX)
Abstract
Presentation thumbnail
Extra-pulmonary vein drivers as a potential mechanism of the antiarrhythmic drug-resistant atrial fibrillation after catheter ablation: Digital twin-guided virtual drug test
Doctor T. Hwang (Seoul, KR)
Abstract
Presentation thumbnail
Digitally enabled acute atrial fibrillation care: safety and cost-analysis in a propensity-matched real-world cohort
Doctor A. Kotb (Eastbourne, GB)
Abstract

Access the full session

Session thumbnail
Artificial intelligence and digital tools in cardiovascular care

The Event

Event poster

ESC Congress 2026

29 August 2026 09:15 CET
You may be interested in
thumbnail
Congress Presentation
Effect of individualized intelligent behavioral interventions on health behaviors for patients with coronary heart disease: an open-label, multicenter, parallel-group, randomized controlled trial
1 September 2025
thumbnail
Congress Presentation
Resistant hypertension improved after 3 months by measuring drug levels to identify non-adherence
27 August 2021
thumbnail
Congress Presentation
Meta-analysis of trials of antihypertensive medication bedtime dosing including individual-patient data from BedMed and BedMed-Frail
31 August 2024
thumbnail
Congress Presentation
Use of a remote telemonitoring platform significantly improves medication optimisation in heart failure patients
27 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources